Global Oncology Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Oncology Drugs Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Antimetabolite
  • 1.2.2 Alkaloid drugs
  • 1.2.3 Hormone
  • 1.2.4 Targeted drug
  • 1.2.5 Platinum-based drugs
  • 1.2.6 Other
• 1.3 Market Analysis by Applications
  • 1.3.1 Blood Cancer
  • 1.3.2 Breast Cancer
  • 1.3.3 Gastrointestinal Cancer
  • 1.3.4 Prostate Cancer
  • 1.3.5 Respiratory/Lung Cancer
  • 1.3.6 Other
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Nigeria Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Roche
  • 2.1.1 Business Overview
  • 2.1.2 Oncology Drugs Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Roche Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 HENGRUI
  • 2.2.1 Business Overview
  • 2.2.2 Oncology Drugs Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 HENGRUI Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 AstraZeneca
  • 2.3.1 Business Overview
  • 2.3.2 Oncology Drugs Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 AstraZeneca Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 QILU
  • 2.4.1 Business Overview
  • 2.4.2 Oncology Drugs Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 QILU Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Sanofi
  • 2.5.1 Business Overview
  • 2.5.2 Oncology Drugs Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Sanofi Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 HANSOH
  • 2.6.1 Business Overview
  • 2.6.2 Oncology Drugs Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 HANSOH Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 LUYE
  • 2.7.1 Business Overview
  • 2.7.2 Oncology Drugs Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 LUYE Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Novartis
  • 2.8.1 Business Overview
  • 2.8.2 Oncology Drugs Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Novartis Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 GuiZhou YiBai
  • 2.9.1 Business Overview
  • 2.9.2 Oncology Drugs Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 GuiZhou YiBai Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Lunan
  • 2.10.1 Business Overview
  • 2.10.2 Oncology Drugs Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Lunan Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Eli Lilly and Company
  • 2.11.1 Business Overview
  • 2.11.2 Oncology Drugs Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Eli Lilly and Company Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Oncology Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Oncology Drugs Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Oncology Drugs Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Oncology Drugs Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Oncology Drugs Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Oncology Drugs Market Analysis by Regions

• 4.1 Global Oncology Drugs Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Oncology Drugs Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Oncology Drugs Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Oncology Drugs Sales and Growth Rate (2014-2019)
• 4.3 Europe Oncology Drugs Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Oncology Drugs Sales and Growth Rate (2014-2019)
• 4.5 South America Oncology Drugs Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Oncology Drugs Sales and Growth Rate (2014-2019)

5 North America Oncology Drugs by Countries

• 5.1 North America Oncology Drugs Sales, Revenue and Market Share by Countries
  • 5.1.1 North America Oncology Drugs Sales and Market Share by Countries (2014-2019)
  • 5.1.2 North America Oncology Drugs Revenue and Market Share by Countries (2014-2019)
• 5.2 United States Oncology Drugs Sales and Growth Rate (2014-2019)
• 5.3 Canada Oncology Drugs Sales and Growth Rate (2014-2019)
• 5.4 Mexico Oncology Drugs Sales and Growth Rate (2014-2019)

6 Europe Oncology Drugs by Countries

• 6.1 Europe Oncology Drugs Sales, Revenue and Market Share by Countries
  • 6.1.1 Europe Oncology Drugs Sales and Market Share by Countries (2014-2019)
  • 6.1.2 Europe Oncology Drugs Revenue and Market Share by Countries (2014-2019)
• 6.2 Germany Oncology Drugs Sales and Growth Rate (2014-2019)
• 6.3 UK Oncology Drugs Sales and Growth Rate (2014-2019)
• 6.4 France Oncology Drugs Sales and Growth Rate (2014-2019)
• 6.5 Russia Oncology Drugs Sales and Growth Rate (2014-2019)
• 6.6 Italy Oncology Drugs Sales and Growth Rate (2014-2019)

7 Asia-Pacific Oncology Drugs by Countries

• 7.1 Asia-Pacific Oncology Drugs Sales, Revenue and Market Share by Countries
  • 7.1.1 Asia-Pacific Oncology Drugs Sales and Market Share by Countries (2014-2019)
  • 7.1.2 Asia-Pacific Oncology Drugs Revenue and Market Share by Countries (2014-2019)
• 7.2 China Oncology Drugs Sales and Growth Rate (2014-2019)
• 7.3 Japan Oncology Drugs Sales and Growth Rate (2014-2019)
• 7.4 Korea Oncology Drugs Sales and Growth Rate (2014-2019)
• 7.5 India Oncology Drugs Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Oncology Drugs Sales and Growth Rate (2014-2019)

8 South America Oncology Drugs by Countries

• 8.1 South America Oncology Drugs Sales, Revenue and Market Share by Countries
  • 8.1.1 South America Oncology Drugs Sales and Market Share by Countries (2014-2019)
  • 8.1.2 South America Oncology Drugs Revenue and Market Share by Countries (2014-2019)
• 8.2 Brazil Oncology Drugs Sales and Growth Rate (2014-2019)
• 8.3 Argentina Oncology Drugs Sales and Growth Rate (2014-2019)
• 8.4 Colombia Oncology Drugs Sales and Growth Rate (2014-2019)

9 Middle East and Africa Oncology Drugs by Countries

• 9.1 Middle East and Africa Oncology Drugs Sales, Revenue and Market Share by Countries
  • 9.1.1 Middle East and Africa Oncology Drugs Sales and Market Share by Countries (2014-2019)
  • 9.1.2 Middle East and Africa Oncology Drugs Revenue and Market Share by Countries (2014-2019)
• 9.2 Saudi Arabia Oncology Drugs Sales and Growth Rate (2014-2019)
• 9.3 UAE Oncology Drugs Sales and Growth Rate (2014-2019)
• 9.4 Egypt Oncology Drugs Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Oncology Drugs Sales and Growth Rate (2014-2019)
• 9.6 South Africa Oncology Drugs Sales and Growth Rate (2014-2019)

10 Global Oncology Drugs Market Segment by Type

• 10.1 Global Oncology Drugs Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Oncology Drugs Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Oncology Drugs Revenue and Market Share by Type (2014-2019)
• 10.2 Antimetabolite Sales Growth and Price
  • 10.2.1 Global Antimetabolite Sales Growth (2014-2019)
  • 10.2.2 Global Antimetabolite Price (2014-2019)
• 10.3 Alkaloid drugs Sales Growth and Price
  • 10.3.1 Global Alkaloid drugs Sales Growth (2014-2019)
  • 10.3.2 Global Alkaloid drugs Price (2014-2019)
• 10.4 Hormone Sales Growth and Price
  • 10.4.1 Global Hormone Sales Growth (2014-2019)
  • 10.4.2 Global Hormone Price (2014-2019)
• 10.5 Targeted drug Sales Growth and Price
  • 10.5.1 Global Targeted drug Sales Growth (2014-2019)
  • 10.5.2 Global Targeted drug Price (2014-2019)
• 10.6 Platinum-based drugs Sales Growth and Price
  • 10.6.1 Global Platinum-based drugs Sales Growth (2014-2019)
  • 10.6.2 Global Platinum-based drugs Price (2014-2019)
• 10.7 Other Sales Growth and Price
  • 10.7.1 Global Other Sales Growth (2014-2019)
  • 10.7.2 Global Other Price (2014-2019)

11 Global Oncology Drugs Market Segment by Application

• 11.1 Global Oncology Drugs Sales Market Share by Application (2014-2019)
• 11.2 Blood Cancer Sales Growth (2014-2019)
• 11.3 Breast Cancer Sales Growth (2014-2019)
• 11.4 Gastrointestinal Cancer Sales Growth (2014-2019)
• 11.5 Prostate Cancer Sales Growth (2014-2019)
• 11.6 Respiratory/Lung Cancer Sales Growth (2014-2019)
• 11.7 Other Sales Growth (2014-2019)

12 Oncology Drugs Market Forecast (2019-2024)

• 12.1 Global Oncology Drugs Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Oncology Drugs Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Oncology Drugs Market Forecast (2019-2024)
  • 12.2.2 Europe Oncology Drugs Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Oncology Drugs Market Forecast (2019-2024)
  • 12.2.4 South America Oncology Drugs Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Oncology Drugs Market Forecast (2019-2024)
• 12.3 Oncology Drugs Market Forecast by Type (2019-2024)
  • 12.3.1 Global Oncology Drugs Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Oncology Drugs Market Share Forecast by Type (2019-2024)
• 12.4 Oncology Drugs Market Forecast by Application (2019-2024)
  • 12.4.1 Global Oncology Drugs Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Oncology Drugs Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology